Research programme: epilepsy therapeutic - Genopia BiomedicalAlternative Names: Chloride channel modulators - Genopia; Epilepsy therapeutic research programme - Genopia Biomedical; Potassium channel modulators - Genopia
Latest Information Update: 24 Feb 2010
At a glance
- Originator GENOPIA Biomedical
- Mechanism of Action Ion channel modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 24 Feb 2010 Discontinued - Preclinical for Epilepsy in Germany (unspecified route)
- 28 Jul 2004 Preclinical trials in Epilepsy in Germany (unspecified route)